---
title: "Pharmacists Algona, LLC SEC filings"
url: https://altstreet.investments/edgar/2165486
kind: edgar-entity
updated: 2026-11-21
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Pharmacists Algona, LLC: SEC filings and what they report

Pharmacists Algona, LLC is a Delaware-formed entity that filed a Form D on 2026-11-19 under Regulation D Rule 506(b), reporting $4.8M raised from 7 investors in an equity offering. James Weichert is listed as executive officer and promoter. No parent platform or related sibling entities were identified, and the minimum investment amount was not disclosed on the filing.

| Field | Value |
| --- | --- |
| Entity | Pharmacists Algona, LLC |
| CIK | 2165486 |
| Filing family | 506(b) |
| Entity type | single deal spv |
| Manager (as filed) | James Weichert |
| Newest fact-bearing filing | November 19, 2026, accession 0001437749-26-037729 |
| Total offering amount (as filed) | $4,800,000 |
| Total sold (as reported) | $4,800,000 |
| Investors (as reported) | 7 |
| Vintage | 2026 |

## Related persons (Form D Item 3)

| Name | Relationship |
| --- | --- |
| James Weichert | Executive Officer, Promoter |


## Filings (1 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| November 19, 2026 | D | Form D | https://www.sec.gov/Archives/edgar/data/2165486/000143774926037729/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/2165486
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002165486&owner=include&count=40
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/2165486
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.
